BNP PARIBAS ARBITRAGE/CALL/RÉMY COINTREAU/130/0.05/21.06.24 Share Price

Warrant

BA3MB

NLBNPFR1W4Z4

Real-time Euronext Paris 10:00:01 17/05/2024 pm IST
0.015 EUR 0.00% Intraday chart for BNP PARIBAS ARBITRAGE/CALL/RÉMY COINTREAU/130/0.05/21.06.24
Current year-96.20%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
17/24/17 0.015 0.00%
16/24/16 0.015 0.00%
15/24/15 0.015 0.00%
14/24/14 0.015 0.00%
13/24/13 0.015 0.00%

Real-time Euronext Paris

Last update May 17, 2024 at 10:00 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying RÉMY COINTREAU
IssuerLogo Issuer BNP Paribas BNP Paribas
BA3MB
ISINNLBNPFR1W4Z4
Date issued 21/11/2023
Strike 130
Maturity 21/06/2024 (32 Days)
Parity 20 : 1
Emission price 0.25
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.435
Lowest since issue 0.015
Spread 0.029
Spread %96.67%

Company Profile

Rémy Cointreau is one of the world's leading producers and distributors of cognac, spirits and liqueurs. Net sales break down by family of products as follows: - cognac (71%): Rémy Martin and LOUIS XIII brands; - liqueurs and spirits (27.1%): liqueur (Cointreau), rum (Mount Gay), brandy (Saint Rémy and Metaxa), single malt whiskies (Bruichladdich, Port Charlotte, Octomore, Westland and Domaine des Hautes Glaces). The remaining sales (1.9%) are distribution of third-party products. Net sales are distributed geographically as follows: Europe/Middle East/Africa (16.8%), America (50.4%) and Asia/Pacific (32.8%).
Sector
-
More about the company

Ratings for Rémy Cointreau

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Rémy Cointreau

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
93 EUR
Average target price
110.2 EUR
Spread / Average Target
+18.44%
Consensus
  1. Stock Market
  2. Warrants
  3. BA3MB Warrant
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW